Table 1.
Demographic and clinical characteristics of the study population according to FIGO Stage at diagnosis (n = 1575)
| Patient Characteristics | FIGO Stage | ||||
|---|---|---|---|---|---|
| All Stages | I-IIa | IIb | III | IV | |
| N | N (%) | N (%) | N (%) | N (%) | |
| All Patients | 1575 | 191 (12.1) | 497 (31.6) | 731 (46.4) | 156 (9.9) |
| Age (years) (mean + SD) Range 21–93 | 48,9 ± 11,5 | 47.9 ± 11.4 | 49.6 ± 11.9 | 48.4 ± 11.3 | 50.9 ± 11.5 |
| Menopausal status | |||||
| Premenopausal | 344 | 41 (11.9) | 102 (29.7) | 175 (50.9) | 26 (7.6) |
| Postmenopausal | 1212 | 148 (12.2) | 386 (31.8) | 548 (45.2) | 130 (10.7) |
| Unknown | 19 | 2 (10.5) | 9 (47.4) | 8 (42.1) | 0 (0) |
| Residence | |||||
| Rural | 976 | 114 (11.7) | 303 (31.0) | 465 (47.6) | 94 (9.6) |
| Urban (Biggest 10 Cities) | 599 | 77 (12.9) | 194 (32.4) | 266 (44.2) | 62 (10.4) |
| HIV Status | |||||
| HIV-positive | 135 | 11 (8.1) | 37 (27.4) | 74 (54.8) | 13 (9.6) |
| negative / unknown | 1440 | 180 (12.5) | 460 (31.9) | 657 (45.6) | 143 (9.9) |
| Parity (mean + SD) Range 0–17 | 6.1 ± 3.0 | 5.6 ± 2.9 | 6.6 ± 3.1 | 6.0 ± 3.0 | 6.5 ± 3.0 |
| Marital Status | |||||
| Unmarried | 12 | 2 (6.7) | 4 (33.3) | 5 (41.7) | 1 (8.3) |
| Early marriage (< 18 years) | 1187 | 146 (12.3) | 380 (32.0) | 550 (46.3) | 111 (9.4) |
| > 18 years / unknown age | 94 | 20 (21.3) | 30 (31.9) | 38 (40.4) | 6 (6.4) |
| Unknown Martial Status | 282 | 23 (8.2) | 83 (29.4) | 138 (48.9) | 38 (13.5) |
| Histology | |||||
| Squamous cell carcinoma | 1488 | 170 (11.4) | 462 (31.1) | 711 (47.8) | 145 (9.8) |
| Adenocarcinoma | 66 | 17 (25.8) | 29 (43.9) | 12 (18.2) | 8 (12.1) |
| Other | 21 | 4 (19.0) | 6 (28.6) | 8 (38.1) | 3 (14.3) |
FIGO International Federation of Gynecology and Obstetrics, SD Standard deviation, HIV Human immunodeficiency virus
% as proportion among stages